Noblezada, Francisco .

HRN: 26-73-50  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2025
CIPROFLOXACIN 500MG (TAB)
02/24/2025
03/03/2025
PO
500mg
BID
UTI
Waiting Final Action 
03/05/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/05/2025
03/11/2025
IVTT
1.5 G
Q6h
Cap-MR; Sepsis; T/c Intraabdominal Infection
Waiting Final Action 
03/05/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/05/2025
03/12/2025
IV
500mg
Q8H
Pneumonia Vs Cholelithiasis; Cannot Totally Rule Out Cholecystitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: